Evidence map›Paper›PMID 40724169›Full record

ArticleInternational journal of environmental research and public health2025

Mobilizing for Health: A Case Study of Kazakhstan's Vaping Ban Advocacy Campaign.

Jamilya Sadykova, Akerke Ayaganova, Kuanysh A Yergaliyev

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jamilya SadykovaNational Coalition 'For Smokefree Kazakstan', 010000 Astana, Kazakhstan.
Akerke AyaganovaStrategic Planning Department, Aktobe Regional State University Named After K.Zhubanov, 030000 Aktobe, Kazakhstan.
Kuanysh A YergaliyevDepartment of Medicine, School of Medicine, Nazarbayev University, 010000 Astana, Kazakhstan.ORCID 0000-0001-6563-802X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article focuses on an advocacy campaign for a complete ban on vaping in Kazakhstan led by the Smokefree Kazakhstan Coalition. Initiated in 2021, the campaign aimed to address the growing public health concerns about vaping among adolescents, which was reflected in a sharp increase in vape use among young people-from 1.6% in 2014 to 5.8% in 2022. Despite facing strong opposition from the vaping industry and political lobbyists, the Coalition gained support from key political figures, public health leaders, and NGOs. Over 32 months, the campaign achieved several key milestones, including the inclusion of criminal liabilities for those involved in the vaping industry, and, in 2024, it eventually joined a number of countries such as Thailand, Qatar, Japan, Singapore, and India in approving a vaping ban. The advocacy efforts relied on public engagement, social media, and coordinated civil society mobilization-including petitions, public meetings, awareness campaigns, and coalition-building among NGOs and health advocacy groups-to overcome industry resistance toward official vaping market ban approvals. This article uses the case study approach with the Power Prism framework to describe and evaluate the advocacy campaign's strategic plan, its political challenges, and the significant impact of public health advocacy in shaping national health policy. The significance of the article lies in the success of the vaping ban in the Kazakhstani context, which may serve as a model for other countries facing similar public health issues, political instability, and industry resistance.

Indexed as

Consumer AdvocacyPublic HealthVapingAdolescentHumansKazakhstanadolescent healthKazakhstanpower prism frameworkpublic health advocacytobacco controlvaping ban

Identifiers

PMID40724169
PMCPMC12294346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.